Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015

Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015

Mineralocorticoid receptor antagonists (MCRA) are part of standard medical therapy for heart failure (HF). The clinical efficacy of MCRA in patients with systolic HF has been proven by randomized clinical trials. The efficacy of this drug group in patients with chronic HF with preserved left ventric...

書目詳細資料
Main Authors:	Yu F Osmolovskaya, I V Zhirov, S N Tereshchenko
格式:	Article
語言:	Russian
出版:	"Consilium Medicum" Publishing house 2015-09-01
叢編:	Терапевтический архив
主題:	aldosterone mineralocorticoid receptor antagonists chronic heart failure
在線閱讀:	https://ter-arkhiv.ru/0040-3660/article/view/31823

相似書籍

Mineralocorticoid receptor antagonists in the treatment of patients with heart failure after myocardial infarction and those with chronic heart failure
由: S N Tereshchenko, et al.
出版: (2013-12-01)

Heart failure: the role for mineralocorticoid receptor antagonists
由: Bertram Pitt
出版: (2014-05-01)

Rational drug therapy of chronic heart failure: the role of mineralocorticoid receptor antagonists: review
由: Natalia V. Safronova, et al.
出版: (2022-01-01)

Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection
由: A. M. Esayan, et al.
出版: (2018-04-01)

Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure
由: Josefin Henrysson, et al.
出版: (2023-02-01)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
由: Daiji Kawanami, et al.
出版: (2021-10-01)

Clinical application of mineralocorticoid receptor antagonists in chronic heart failure
由: MG Bubnova
出版: (2014-12-01)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
由: Yuta Tezuka, et al.
出版: (2021-03-01)

Mineralocorticoid receptors in the pathophysiology of vascular inflammation and atherosclerosis.
由: Mary Elizabeth Moss, et al.
出版: (2015-09-01)

Serum potassium level and mineralocorticoid receptor antagonist dose in a large cohort of chronic heart failure patients
由: Pascal R. D. Clephas, et al.
出版: (2023-04-01)

Effectiveness and safety of mineralocorticoid receptor antagonists in heart failure patients with and without diabetes: a systematic review and meta-analysis
由: Arga Setyo Adji, et al.
出版: (2024-11-01)

A comprehensive review of finerenone—a third-generation non-steroidal mineralocorticoid receptor antagonist
由: Shuhui Zhai, et al.
出版: (2024-09-01)

The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review
由: Irina N. Bobkova
出版: (2023-11-01)

Expression of genes encoding mineralocorticoid biosynthetic enzymes and the mineralocorticoid receptor, and levels of mineralocorticoids in the bovine follicle and corpus luteum
由: Memory MUKANGWA, et al.
出版: (2019-12-01)

Changes of myocardial fibrosis markers with the use of beta-blockers and mineralocorticoid receptor antagonists in patients with heart failure with mid-range ejection fraction of ischemic origin
由: O. A. Osipova, et al.
出版: (2021-11-01)

Effects of spironolactone and eplerenone on left ventricular diastolic function and neurohumoral factors in patients with heart failure
由: N. A. Nuritdinov, et al.
出版: (2020-12-01)

Obesity, aldosterone excess, and mineralocorticoid receptor activation: Parallel or intersected circumstances?
由: Houry Puzantian, et al.
出版: (2024-12-01)

Mineralocorticoid receptor antagonists for chronic heart failure: a meta-analysis focusing on the number needed to treat
由: Chang Geng, et al.
出版: (2023-11-01)

Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review
由: Kisho Miyasako, et al.
出版: (2024-12-01)

Mineralocorticoid Receptor-Dependent Impairment of Baroreflex Contributes to Hypertension in a Mouse Model of Primary Aldosteronism
由: Luo Shi, et al.
出版: (2019-11-01)

The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
由: Ulrich Kintscher, et al.
出版: (2023-06-01)

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
由: Nappi J, et al.
出版: (2011-06-01)

Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta‐Analysis
由: Chien‐Wei Huang, et al.
出版: (2025-02-01)

The effectiveness of eplerenone in clinical practice from the standpoint of evidence-based medicine (twenty years on the guard of life)
由: A. G. Evdokimova, et al.
出版: (2023-01-01)

Thiazides and mineralocorticoid receptor antagonists in chronic kidney disease
由: Andrei Niculae, et al.
出版: (2022-03-01)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
由: Nina Vodošek Hojs, et al.
出版: (2021-06-01)

Cardiac Mineralocorticoid Receptor and the Na+/H+ Exchanger: Spilling the Beans
由: Irene Lucía Ennis, et al.
出版: (2021-01-01)

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
由: Greg H. Tesch, et al.
出版: (2017-05-01)

Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy
由: S. R. Gilyarevsky, et al.
出版: (2023-10-01)

Heart failure as a complication of myocardial infarction: rational therapy. Case report
由: Igor V. Zhirov, et al.
出版: (2022-12-01)

Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease
由: Dong-Lim Kim, et al.
出版: (2023-02-01)

PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy
由: Stephen eOrena, et al.
出版: (2013-10-01)

Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice
由: Marie Pieronne‐Deperrois, et al.
出版: (2021-06-01)

Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology
由: Sofia S. Pereira, et al.
出版: (2021-04-01)

MINERALOCORTICOID RECEPTOR ANTAGONISTS THERAPY IN RESISTANT HYPERTENSION: TIME TO IMPLEMENT NEW GUIDELINES?
由: Giuseppe eMaiolino, et al.
出版: (2015-02-01)

Mineralocorticoid receptor antagonists in chronic central serous chorioretinopathy
由: Ana Sanhueza, et al.
出版: (2020-09-01)

Mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy: systematic review and meta-analyses
由: Camila Q. Felipe, et al.
出版: (2022-06-01)

Endogenous bufadienolides, mineralocorticoid receptor antagonists and fibrosis in chronic kidney disease
由: Mai Rosenberg, et al.
出版: (2024-09-01)

Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research
由: Argen Mamazhakypov, et al.
出版: (2023-01-01)

Effects of Mineralocorticoid Receptor Antagonists on Atrial Fibrillation Occurrence: A Systematic Review, Meta‐Analysis, and Meta‐Regression to Identify Modifying Factors
由: Joachim Alexandre, et al.
出版: (2019-11-01)